Keyphrases
Chemotherapy Resistance
100%
Alternative Splicing
100%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Cisplatin
100%
Germline mutation
100%
Splice Isoforms
100%
PARP Inhibitor (PARPi)
100%
Exon 11
50%
Cas9 Protein
25%
Germ Cells
12%
Breast Cancer Patients
12%
Gene Editing
12%
Acquired Resistance
12%
Cancer Cells
12%
Clinical Impact
12%
Cell Tumor
12%
Isoform Expression
12%
Cancer Cell Lines
12%
Therapeutic Response
12%
Ovarian Cancer Patients
12%
Frameshift mutation
12%
RNA Splicing
12%
Gene Overexpression
12%
Nonsense-mediated mRNA Decay
12%
Splice Variant
12%
Residual Activity
12%
BRCA mutation
12%
Inhibitor Treatment
12%
Platinum Compounds
12%
Cisplatin Resistance
12%
Inhibitor Compound
12%
Expression Response
12%
PARP Inhibitor Resistance
12%
Germline BRCA1/2 mutation
12%
Overexpression Experiments
12%
Spliceosome Inhibitors
12%
Biochemistry, Genetics and Molecular Biology
Isoform
100%
BRCA1
100%
Cisplatin
100%
Germline Mutation
100%
Poly ADP Ribose Polymerase
100%
Exon
40%
Cancer Cell
20%
Germline
10%
Germ Cell
10%
CRISPR/Cas9
10%
Genome Editing
10%
Frameshift Mutation
10%
Alternative Splicing
10%
Nonsense-Mediated Decay
10%
Spliceosome
10%